SEARCH FOR PRODUCTS
 
SEARCH BY COMPANY
 
SEARCH FOR PROTOCOLS
 
FIND A KIT
 
Featured Catalog

Order your free reference guide

Login
E-Mail:
Password:
Remember Me

Not Registered?

Forgot Your Password?




BioSupplyNet Featured Protocol exclusively sponsored by:
 

Products for this protocol


"Accelerating Customers' success through Leadership in Life Science, High Technology and Service"
 
Generation of Transgenic Xenopus laevis
 
Shoko Ishibashi 1, Kristin L. Kroll 2, and Enrique Amaya1, 3
 
1 The Healing Foundation Centre, Faculty of Life Sciences, University of Manchester, Manchester M13 9PT,United Kingdom
 
2 Department of Molecular Biology and Pharmacology, Washington University School of Medicine, St. Louis, MO 63110, USA
 
3 Corresponding author (enrique.amaya@manchester.ac.uk)
 

See More Protocols
Originally published in CSH Protocols
 
Generation of Transgenic Xenopus laevis: I. High-Speed Preparation of Egg Extracts
 
Please cite as CSH Protocols; 2007; doi:10.1101/pdb.prot4838

INTRODUCTION
 
Manipulating genes specifically during later stages of amphibian embryonic development requires fine control over the time and place of expression. These protocols describe an efficient nuclear-transplantation-based method of transgenesis developed for Xenopus laevis. The approach enables stable expression of cloned gene products in Xenopus embryos. Because the transgene integrates into the genome prior to fertilization, the resulting embryos are not chimeric, eliminating the need to breed to the next generation to obtain nonmosaic transgenic animals. The procedure is based on restriction-enzyme-mediated integration (REMI) and can be divided into three parts: (I) high-speed preparation of egg extracts, (II) sperm nuclei preparation, and (III) nuclear transplantation. This protocol describes the method for the high-speed preparation of egg extracts. Briefly, a crude, cytostatic factor (CSF)-arrested egg extract (i.e., cytoplasm arrested in meiotic metaphase) is prepared. These extracts are driven into the interphase stage of the cell cycle by addition of calcium, and high-speed centrifugation is performed to obtain a purer cytoplasmic fraction. This fraction promotes swelling of sperm nuclei, but does not promote DNA replication. By adding the egg extract to the reaction, the sperm chromatin partially decondenses, facilitating integration of plasmid DNA into the genome.
 
RELATED INFORMATION
For details on basic Xenopus procedures used in this protocol, please see Handling Xenopus laevis Adults , Inducing Ovulation in Xenopus laevis, Xenopus laevis Egg Collection and Dejellying Xenopus laevis Embryos.
 
MATERIALS
 
Reagents
 
  • 1 M CaCl2
     
  • XB Salts (20X)
     
    • 2 mM CaCl2
       
    • 2 M KCl
       
    • 20 mM MgCl2
       
    • Filter-sterilize. Store at 4°C.
       
  • Protease inhibitor mix (1000X)
     
    • Chymostatin
       
    • DMSO
       
    • Leupeptin
       
    • Pepstatin
       
    • Dissolve each of the protease inhibitors (chymostatin, leupeptin, and pepstatin) to a final concentration of 10 mg/mL in DMSO. Store the solution in small aliquots at -20°C.
       
  • CSF-XB buffer with protease inhibitors, freshly prepared and stored on ice
     
    • 5 mM EGTA
       
    • 10 mM HEPES (pH 7.7)
       
    • 1 mM MgCl2
       
    • This is added in addition to the MgCl2 present in XB salts; the final concentration of MgCl2 is 2 mM.
       
    • 1X Protease inhibitor mix
       
    • 50 mM sucrose
       
    • 1X XB salts
       
  • Cysteine solution (1X XB salts containing 2.0% L-cysteine hydrochloride 1-hydrate, pH 7.8), freshly prepared
     
  • Energy mix
     
    • 20 mM ATP
       
    • 150 mM creatine phosphate
       
    • 20 mM MgCl2
       
    • Store in 0.1-ml aliquots at -20°C.
       
  • Extract buffer, freshly prepared and stored on ice
     
    • 10 mM HEPES (pH 7.7)
       
    • 50 mM sucrose
       
    • 1X XB salts
       
  • 10 mg/mL Hoechst No. 33342, diluted 1:100 prior to use (optional; see Step 21)
     
  • 1000 U/mL human chorionic gonadotropin (HCG)
     
  • Liquid nitrogen
     
  • 10X Marc's modified Ringer's (MMR), diluted to 1X prior to use
     
    • 20 mM CaCl2
       
    • 50 mM HEPES (pH 7.5)
       
    • 20 mM KCl
       
    • 10 mM MgCl2
       
    • 1 M NaCl
       
    • Adjust pH with NaOH to 7.5. Sterilize by autoclaving.
       
  • 100 U/mL pregnant mare serum gonadotropin (PMSG)
     
  • Xenopus laevis, adult female
     
Equipment
 
  • Beakers for egg collection (see Step 5)
     
  • Buckets or containers for holding female frogs (e.g., 4-L plastic beakers with mesh lids)
     
  • Needles (18 and 26 gauge)
     
  • Pasteur pipette, wide bore
     
  • Syringes (1 mL)
     
  • Tubes, microcentrifuge (0.5 mL)
     
  • Tubes, thick-wall polycarbonate (Beckman, 349622)
     
  • Tubes, ultraclear (14 x 95 mm; Beckman, 344060)
     
  • Ultracentrifuge and rotors (e.g., Beckman TL-100 with rotors SW 40 Ti and TLA-100.3)
     
METHOD
 
All solutions should be prepared before the extraction process begins. The procedure should be carried through all steps promptly once it is initiated. Optimally, the high-speed centrifugation should begin within 45-60 min of dejellying the eggs.
 
Collection and Preparation of Xenopus Eggs
 
  1. About 3-5 d prior to HCG injection, prime 8-12 adult female X. laevis by injecting 50 U of PMSG into the dorsal lymph sac using a 26-gauge needle.
     
  2. The evening before extract preparation, inject each frog with 500 U HCG.
     
  3. Place the frogs into 2 L of 1X MMR (2 frogs/container), and keep them at 15°C-18°C overnight (12-14 h).
     
    Because one frog with lysing or activating eggs can compromise the whole extract preparation, we prefer to separate the frogs into pairs for the ovulation.
     
  4. The next morning, screen the quality of the eggs from each container before mixing all the eggs. Leave out all the eggs released in any container with signs of mottled, lysing, or dying eggs from the extract preparation, as these can affect the quality of the extracts obtained.
     
  5. Gently, manually expel eggs from each frog into large beakers containing 1X MMR.
     
  6. Collect unbroken eggs with even pigmentation. Good eggs can also be collected from the 1X MMR in the frog buckets.
     
    The total volume of eggs should be >100 mL from the 8-12 females.
     
  7. To dejelly the eggs, remove as much MMR as possible from the eggs. Add a small amount of cysteine solution, and swirl the eggs. Replace with fresh cysteine solution several times during dejellying.
     
    Dejellying should be initiated separately for different batches of eggs. Discard any batches that show breakage or premature egg activation. Egg activation can be recognized by constriction of the animal pole region of the eggs. The rest of the eggs can then be combined.
     
  8. Wash the eggs in ~35 mL of extract buffer, four times.
     
  9. Wash the eggs in 25 mL of CSF-XB with protease inhibitors, twice.
     
  10. Using a wide-bore Pasteur pipette, transfer the eggs into Beckman ultraclear tubes. Allow the eggs to settle. Remove as much CSF-XB as possible.
     
  11. Centrifuge the eggs using a Beckman SW 40 Ti rotor at 1000 rpm (150g) for ~60 sec at 4°C. Remove excess solution from the top of the packed eggs. This step packs the eggs, but does not crush them yet.
     
  12. High-Speed Extraction of Xenopus Eggs
     
  13. Centrifuge the eggs at 10,000 rpm (16,000g) for 10 min at 4°C to crush the eggs. The eggs should be separated into three layers: lipid (top), cytoplasm (center), and yolk (bottom).
     
  14. Collect the cytoplasmic layer from each tube with an 18-gauge needle by inserting the needle at the base of the cytoplasmic layer. Transfer the cytoplasm to a fresh ultraclear Beckman tube on ice.
     
  15. Add protease inhibitors to the isolated cytoplasm to a final concentration of 1X. Recentrifuge the cytoplasm at 16,000g for 10 min at 4°C.
     
  16. Collect the clarified cytoplasm as described in Step 13.
     
    Expect to obtain 0.75-1 mL cytoplasm/frog.
     
  17. Add 1/20 of the extract volume of energy mix to the sample. Transfer the cytoplasm into thick-walled polycarbonate tubes.
     
    Tubes hold about 3 mL each and should be at least half full.
     
  18. Add 1 M CaCl2 to each tube to a final concentration of 0.4 mM. Incubate the tubes for 15 min at room temperature.
     
    This inactivates CSF and pushes the extract into interphase.
     
  19. Balance the tubes. Centrifuge them in a Beckman TL-100 ultracentrifuge using a TLA-100.3 rotor at 70,000 rpm for 1.5 h at 4°C.
     
    The cytoplasm will fractionate into four layers, top to bottom: lipid, cytosol, membrane/mitochondria, and glycogen/ribosomes.
     
  20. Remove the cytosolic layer from each tube (~1 mL if 2-3 mL were loaded into the tube) by inserting a syringe into the top of the tube through the lipid layer.
     
  21. Transfer the cytosolic fraction to fresh tubes. Recentrifuge the samples at 70,000 rpm for 20 min at 4°C.
     
  22. Aliquot the supernatant into 25-µL aliquots in 0.5-mL tubes. Quick-freeze the aliquots in liquid nitrogen. Store them at -80°C until use.
     
    To test the quality of the extracts, add sperm nuclei to an aliquot of extract and stain with Hoechst to determine whether the nuclei visibly swell (i.e., thicken and lengthen) within 10 min of addition at room temperature.
     
Generation of Transgenic Xenopus laevis: II. Sperm Nuclei Preparation
 
Please cite as CSH Protocols; 2007; doi:10.1101/pdb.prot4838
 
INTRODUCTION
 
Manipulating genes specifically during later stages of amphibian embryonic development requires fine control over the time and place of expression. These protocols describe an efficient nuclear-transplantation-based method of transgenesis developed for Xenopus laevis. The approach enables stable expression of cloned gene products in Xenopus embryos. Because the transgene integrates into the genome prior to fertilization, the resulting embryos are not chimeric, eliminating the need to breed to the next generation to obtain nonmosaic transgenic animals. The procedure is based on restriction-enzyme-mediated integration (REMI) and can be divided into three parts: (I) high-speed preparation of egg extracts, (II) sperm nuclei preparation, and (III) nuclear transplantation. This protocol describes a method for the preparation of sperm nuclei from Xenopus laevis. Sperm suspensions are prepared by filtration and centrifugation, and then treated with lysolecithin to disrupt the plasma membrane of the cells. Sperm nuclei can be stored frozen in small aliquots at -80°C.

 
MATERIALS
 
Reagents
 
  • 10% bovine serum albumin (BSA; Sigma, A7906), freshly prepared and stored on ice
     
  • 10 mg/mL Hoechst No. 33342, diluted 1:00 prior to use
     
  • 1000 U/mL human chorionic gonadotropin (HCG)
     
  • Liquid nitrogen
     
  • 10 mg/mL L-{alpha}-lysolecithin, egg yolk (Calbiochem, 440154)
     
    Store the solid stock at -20°C. Discard the stock powder if it becomes sticky. Prepare the 10 mg/mL solution immediately before use at room temperature.
     
  • 10X Marc's modified Ringer's (MMR), diluted to 1X prior to use and stored on ice
     
    • 20 mM CaCl2
       
    • 50 mM HEPES (pH 7.5)
       
    • 20 mM KCl
       
    • 10 mM MgCl2
       
    • 1 M NaCl Adjust pH with NaOH to 7.5. Sterilize by autoclaving.
       
  • 2X nuclear preparation buffer (NPB), freshly prepared (to a concentration of 1X) and stored on ice
    • 2 mM dithiothreitol
       
    • 2 mM EDTA (pH 8.0)
       
    • 30 mM HEPES
       
    • 1 mM spermidine trihydrochloride
       
    • 0.4 mM spermine tetrahydrochloride
       
    • 500 mM sucrose
       
  • 100 U/mL pregnant mare serum gonadotropin (PMSG)
     
  • Sperm dilution buffer (SDB)
     
    • 75 mM KCl
       
    • 0.5 mM spermidine trihydrochloride
       
    • 0.2 mM spermine tetrahydrochloride
       
    • 250 mM sucrose
       
    • Add ~80 µL of 0.1 N NaOH per 20 mL of solution to titrate the pH to 7.3-7.5. Store 0.5-1 mL aliquots at -20°C.
       
  • Sperm storage buffer (SSB), freshly prepared and stored on ice
     
    • 0.3% bovine serum albumin (BSA)
       
    • 30% glycerol
       
    • 1X nuclear preparation buffer (NPB)
       
  • 0.1% tricaine methanesulfonate, prepared in 0.1% sodium bicarbonate
     
  • Xenopus laevis, adult males
     
Equipment
 
  • Centrifuge and rotor (e.g., Sorvall HB-4 swinging bucket rotor)
     
  • Cheesecloth
     
  • Dissection tools: forceps and scissors
     
  • Fluorescence microscope
     
  • Funnel
     
  • Gloves, latex
     
  • Hemocytometer
     
  • Needles (26 gauge)
     
  • Paper towels
     
  • Petri dishes (60 mm)
     
  • Pipettes, plastic (5 and 10 mL)
     
  • Pipetman tips (1 mL and 200 µL)
     
  • Razor blade
     
  • Syringes (1 mL)
     
  • Tubes (14 mL; Falcon, 2059)
     
  • Tubes, microcentrifuge (1.5 mL)
     
METHOD
 
  1. About 3-5 d prior to HCG injection, prime one or two male X. laevis by injection with 50 U of PMSG using a 26-gauge needle fitted to a 1-mL syringe.
     
  2. Twelve to fifteen hours before nuclei preparation, inject the males with 500 U of HCG.
     
  3. Anesthetize the male by immersion in tricaine for at least 20 min. Pith it.
     
  4. Isolate the testes with dissecting scissors. Roll them on a paper towel to remove blood, blood vessels, and adhering fat.
     
    For details on this procedure, please consult Isolating Xenopus laevis Testes.
     
  5. Wash the testes briefly in a 60-mm Petri dish containing cold 1X MMR. Remove any attached pieces of fat or debris with forceps.
     
  6. Transfer the cleaned testes to a dry 60-mm Petri dish. Macerate the testes with a pair of clean forceps until clumps are no longer visible to the naked eye.
     
  7. Add 2 mL of cold 1X NPB. Mix well by pipetting the solution up and down with a 10-mL plastic pipette.
     
  8. Filter the sperm suspension through four thicknesses of cheesecloth placed into a funnel. Collect the filtrate in a 14-mL tube.
     
  9. Rinse the Petri dish with an additional 3 mL of cold 1X NPB. Force this through the cheesecloth into the 14-mL tube.
     
  10. Add 5 mL of cold 1X NPB to the funnel. Wearing gloves, squeeze the cheesecloth by hand to force any remaining liquid through the funnel into the 14-mL tube.
     
  11. Pellet the sperm by centrifugation at 3000 rpm for 10 min at 4°C using a swinging bucket rotor with the appropriate adapters.
     
  12. During the centrifugation, allow 1 mL of 1X NPB to equilibrate to room temperature.
     
  13. Decant the supernatant obtained from Step 11. Resuspend the sperm in 9 mL of 1X NPB using a 10-mL plastic pipette.
     
  14. Recentrifuge the sperm at 3000 rpm for 10 min at 4°C. Decant the supernatant.
     
  15. Resuspend the pellet with a 1-mL pipette tip in the 1 mL of room-temperature 1X NPB (from Step 12).
     
  16. Add 50 µL of freshly made 10 mg/mL lysolecithin. Mix gently. Incubate for 5 min at room temperature.
     
  17. Add 10 mL of cold 1X NPB supplemented with 3% BSA to the suspension to stop the reaction.
     
  18. Centrifuge the samples at 3000 rpm for 10 min at 4°C. Decant the supernatant.
     
  19. Resuspend the pellet in 5 mL of cold 1X NPB supplemented with 0.3% BSA. Mix well by pipetting with a 5-mL plastic pipette.
     
  20. Centrifuge at 3000 rpm for 10 min at 4°C. Decant the supernatant carefully.
     
  21. Resuspend the pellet in 500 µL of SSB. Transfer the suspension into a 1.5-mL tube.
     
  22. Count the number of sperm nuclei using a hemocytometer.
     
    For details on this procedure, please consult Estimation of Cell Number by Hemocytometry Counting.
     
    1. Cut off the end of a 200-µL pipette tip with a razor blade.
       
    2. Mix the sperm nuclei well by pipetting.
       
    3. Dilute 1 µL of the sperm nuclei with 100 µL of SDB.
       
    4. Add 1 µL of the diluted Hoechst reagent.
       
    5. Visualize the sperm nuclei under a fluorescence microscope.
       
    For a 1:100 dilution, we typically obtain counts of 100 x 104 to 200 x 104 nuclei/mL in a 1 x 1 x 0.1-mm square of an improved Neubauer hemocytometer. At this concentration, the undiluted stock contains 1x 105 to 2 x 105 nuclei/µL. See Troubleshooting.
     
  23. For best cryopreservation of the sperm, leave fresh nuclei overnight at 4°C to allow the glycerol to penetrate.
     
  24. The next day, divide the sperm into 20-µL aliquots. Fast-freeze the samples in liquid nitrogen. Store the frozen aliquots at -80°C.
     
TROUBLESHOOTING
 
Problem: Sperm stock is substantially less concentrated (i.e., a count of <50 for a 1:100 dilution).
 
[Step 22]
 
Solution: Let the sperm settle for a few hours or overnight and remove some of the supernatant.
 
Problem: Sperm stock is substantially contaminated with debris.
 
[Step 22]
 
Solution: Make sure not to treat sperm nuclei longer than 5 min with lysolecithin. After the treatment with lysolecithin, the precipitate of sperm nuclei is loose. Be careful when you decant the supernatant.
 
At Step 16, digitonin (Sigma) at a final concentration of 100 µg/mL can be used instead of lysolecithin. Digitonin is more specific for the plasma membrane, leaving the nuclear membranes intact.
 

 
Generation of Transgenic Xenopus laevis: III. Sperm Nuclear Transplantation
 
Please cite as CSH Protocols; 2007; doi:10.1101/pdb.prot4840
 
INTRODUCTION
Manipulating genes specifically during later stages of amphibian embryonic development requires fine control over the time and place of expression. These protocols describe an efficient nuclear-transplantation-based method of transgenesis developed for Xenopus laevis. The approach enables stable expression of cloned gene products in Xenopus embryos. The procedure is based on restriction-enzyme-mediated integration (REMI) and can be divided into three parts: (I) high-speed preparation of egg extracts, (II) sperm nuclei preparation, and (III) nuclear transplantation. This protocol describes a method for the nuclear transplantation in Xenopus laevis. Permeabilized sperm nuclei are incubated briefly with linearized plasmid DNA, after which egg extract and a small amount of restriction enzyme are added. The egg extract partially decondenses the chromosomes, and the restriction enzyme stimulates recombination by creating double-strand breaks, facilitating integration of DNA into the genome. Diluted nuclei are transplanted into unfertilized eggs. Because the transgene integrates into the genome prior to fertilization, the resulting transgenic embryos are not chimeric and there is no need to breed to the next generation in order to obtain nonmosaic transgenic animals.
 
MATERIALS
 
Reagents
 
  • 1.0% agarose, prepared in 0.1X MMR
     
  • Cysteine solution (1X MMR containing 2.5% L-cysteine hydrochloride 1-hydrate, pH 7.8-8.0), prepared immediately before use
     
  • Ficoll
     
  • 10 mg/mL gentamycin (1000X stock)
     
  • High-speed egg extract (see Generation of Transgenic Xenopus laevis: I. High-Speed Preparation of Egg Extracts, above)
     
  • 1000 U/mL human chorionic gonadotropin (HCG)
     
  • 100 ng/µL linearized plasmid
     
  • Any enzyme can be used for linearization of plasmid. Digest the DNA using standard conditions, and purify by phenol/chloroform extraction and ethanol precipitation. There is no need to gel-purify the plasmid.
     
  • 100 mM MgCl2
     
  • 10X Marc's modified Ringer's (MMR), diluted to 1X prior to use and stored on ice
     
    • 20 mM CaCl2
       
    • 50 mM HEPES (pH 7.5)
       
    • 20 mM KCl
       
    • 10 mM MgCl2
       
    • 1 M NaCl
       
    • Adjust pH with NaOH to 7.5. Sterilize by autoclaving.
       
  • 100 U/mL pregnant mare serum gonadotropin (PMSG)
     
  • Restriction enzyme
     
  • Sperm dilution buffer (SDB)
     
    • 75 mM KCl
       
    • 0.5 mM spermidine trihydrochloride
       
    • 0.2 mM spermine tetrahydrochloride
       
    • 250 mM sucrose
       
    • Add ~80 µL of 0.1 N NaOH per 20 mL of solution to titrate the pH to 7.3-7.5. Store 0.5-1 mL aliquots at -20°C.
       
  • Sperm nuclei (1 x 105 to 2 x 105 nuclei/µL; see Generation of Transgenic Xenopus laevis: II. Sperm Nuclei Preparation, above)
     
  • Xenopus laevis, adult females
     
Equipment
 
  • Beaker for egg collection (see Step 14)
     
  • Dishes (24 well), coated with agarose (optional; see Step 26)
     
  • Forceps
     
  • Ice
     
  • Incubator
     
  • Injection microscope
     
  • Micromanipulator
     
  • Micropipette puller (Model P-87, Sutter Instruments)
     
  • Mineral oil (Sigma, M8410)
     
  • Needles (26 gauge)
     
  • Needles (30 µL), transplantation (Drummond, Microcaps 1-000-0300)
     
  • Ocular micrometer from a dissecting microscope
     
  • Parafilm
     
  • Pasteur pipettes, wide bore
     
  • Petri dishes (60 mm and 10 cm)
     
  • Plastic box with lid, empty (approximate dimensions: W 15 cm x L 9 cm x H 5 cm)
     
  • Pipetman pipette tips (200 µL), clipped
     
  • Syringe pump (Harvard Apparatus, #552222)
     
  • Syringes (1 mL)
     
  • Syringes, gas-tight (2.5 mL) (Hamilton)
     
  • Tubing, plastic (ID = 0.7 mm, OD = 2.4 mm)
     
  • Tubing, Tygon (ID = 1/32 in., OD = 3/32 in.)
     
  • Weighing boats (35 x 35 mm)
     
  • The weighing boats are used as templates during the preparation of injection dishes (see Steps 9-11). This size template holds about 400 X. laevis eggs.
     
  • METHOD
     
    Preparation of Transplantation System
     
    1. Set the micropipette puller using the following conditions: p = 50, v = 100, and t = 5.
       
    2. Use the puller to produce large transplantation needles with long, gently sloping tips.
       
    3. Using the ocular micrometer from a dissecting microscope for measurement, clip the needles with a forceps to produce a beveled tip with a diameter of 80-100-µm (Fig. 1B ).
       

    4.  
      Figure 1. Nuclear transplantation apparatus. (A) This protocol uses an oil-filled injection system for the nuclear transplantations. The syringe and tubing are filled with mineral oil and the infusion pump depresses the syringe plunger, resulting in a constant, desirable flow rate. (B) The transplantation needle has a gently sloping tip and is clipped with forceps to produce a beveled 80-100-µm-wide tip.

       
    5. Set up the transplantation apparatus (see Fig. 1A for details). Fill the plastic tubing and gas-tight syringe with mineral oil. Set the flow rate of the syringe pump at 0.6 µL/min. Start the infusion pump before injection to stabilize the flow.
       
    6. Preparation of Transgenic Nuclei
       
    7. Using a clipped 200-µL pipette tip, mix 4 µL of sperm nuclei (~4 x 105 to 8 x 105 nuclei) with 1-2 µL of linearized plasmid (100 ng/µL). Incubate for 5 min at room temperature.
       
    8. Dilute 0.5 µL of the restriction enzyme of choice with 4.5 µL of H2O.
       
    9. Mix 1 µL of the diluted enzyme with 18 µL of SDB, 2 µL of 100 mM MgCl2, and 2 µL of high-speed egg extract.
       
    10. Add the enzyme solution from Step 7 to the sperm/DNA mixture from Step 5. Mix well by gently pipetting using a clipped 200-µL pipette tip. Incubate for 15 min at room temperature.
       
    11. Preparation of Injection Dishes
       
      These dishes are designed for injection of transgenic nuclear material into Xenopus eggs (during Steps 16-26) and should be prepared in advance.
       
    12. Pour the 1.0% agarose solution into 60-mm Petri dishes.
       
    13. Before the agarose solidifies, lay a weighing boat onto each plate as a template.
       
    14. After the agarose solidifies, remove the templates. Wrap the dishes in Parafilm, and store them at 4°C until use.
       
    15. Preparation of Recipient Eggs
       
    16. About 3-5 d prior to HCG injection, prime two adult female X. laevis by injecting 50 U of PMSG into the dorsal lymph sac using a 26-gauge needle fitted to a 1-mL syringe.
       
    17. Twelve to fifteen hours before transplantation, inject each frog with 500 U of HCG. Store the frogs overnight at 15°C-18°C.
       
    18. While the enzyme reaction is incubating (Step 8), manually expel the eggs from the frogs. Squeeze the eggs directly into a large dry beaker.
       
    19. Add the cysteine solution immediately to the eggs to ensure egg quality. Dejelly the eggs in the cysteine solution.
       
      This usually takes ~10 min, so by the time the eggs are ready, the enzyme reaction (Step 8) is nearly complete.
       
    20. Wash the dejellied eggs with 1X MMR at least three times. Use a wide-bore Pasteur pipette to transfer the eggs to injection dishes containing 0.4X MMR supplemented with 6% Ficoll and 10 µg/mL gentamycin. Fill the square space with eggs so that no gap is left between the eggs.
       
    21. Place the injection dish on an empty plastic box half-filled with ice. Place the box and eggs under the injection microscope.
       
      This should provide a transplantation temperature of ~16°C.
       
    22. Injection of Transgenic Nuclei
       
    23. After incubation with the enzyme (Step 8), mix the sperm nuclei gently by pipetting with a clipped 200-µL pipette tip. Transfer 5 µL of the reaction into 150 µL of SDB equilibrated to room temperature.
       
      Keep decondensed sperm nuclei at room temperature and transplant them within 1 h, but preferably within 30 min.
       
    24. Attach a piece of Tygon tubing to the end of a clipped 200-µL pipette tip (Fig. 2A ).
       

    25.  
      Figure 2. Loading the transplantation needle. (A) The reaction mix (containing diluted, restriction-enzyme-treated sperm nuclei) is drawn into a clipped, 200-µL, yellow pipette tip attached to ~0.5-1cm of Tygon tubing. (B) The 200-µL pipette tip containing the Tygon tubing and dilute sperm nuclei is carefully detached from the Pipetman and connected to the blunt end of the transplantation needle using the tubing. The needle is gently loaded with the dilute sperm nuclear reaction by gravity. This is done by slowly increasing the angle of the pipette tip/tubing/needle so that the mixture flows gently into the needle. Once the needle is completely filled, it is detached from the tubing and is ready to connect to the infusion pump. The remaining sperm mixture can be set aside horizontally and used to reload another needle, if two people are injecting simultaneously or if a needle is accidentally damaged or blocked.

       
    26. Using this tip, mix the diluted sperm nuclei well, but avoid making bubbles. Fill the clipped 200-µL pipette tip with the diluted sperm suspension.
       
    27. Carefully detach the clipped 200-µL pipette tip from the Pipetman, keeping the tip horizontal. Attach the end of the Tygon tubing opposite the tip to the blunt end of a transplantation needle.
       
    28. Backfill the transplantation needle by slowly increasing the angle of the pipette tip/tubing/needle so that the mixture flows gently into the needle (Fig. 2B).
       
      You can keep the 200-µL pipette tip with the remaining nuclei by placing it horizontally, in case you need to load another needle.
       
    29. Attach the needle to the mineral-oil-filled tube connected to the syringe in the syringe pump.
       
    30. Check the flow on the pump and start injecting. Keep the needle inside each egg for ~0.5 sec. Move the needle fairly rapidly from egg to egg, piercing the plasma membrane of each egg with a single, sharp motion.
       
      We usually transplant for ~15-20 min. See Troubleshooting.
       
    31. Incubation of Transgenic Embryos
       
    32. After injection, transfer the embryos in their injection dishes to an incubator set at 16°C.
       
    33. When the embryos reach the four-cell stage (about 3-4 h after injection at 16°C), use a wide-bore Pasteur pipette to transfer normally dividing embryos gently to a 10-cm Petri dish containing 0.1X MMR supplemented with 6% Ficoll and 10 µg/mL gentamycin.
       
      Alternatively, the embryos can be transferred in groups of up to four or so embryos per well into 24-well dishes.
       
      See Troubleshooting.
       
    34. The next day (when embryos are around stage 12), transfer healthy embryos to a new 10-cm Petri dish (or 24-well dishes) containing 0.1X MMR supplemented with 10 µg/mL gentamycin.
       
      Because of the large needle tip used for transplantations, embryos often develop large blebs at the site of injection. These blebs occur when cells are forced out of the hole left in the vitelline membrane at the injection site. They generally do not affect development, falling off at the neurula or tailbud stages.
       
      See Troubleshooting.
       
    35. Incubate embryos at 14°C-22°C until they reach the stage of interest for your specific experimental needs.
       
      See Troubleshooting.
       
    TROUBLESHOOTING
     
    Problem: The needle is blocked by debris during transplantation.
     
    [Step 24]
     
    Solution: Change the needle or try to fix by pinching the tube or cutting the tip of needle using forceps.
     
    Problem: No cleaving eggs
     
    [Step 26]
     
    Solutions: (1) Make sure that injection needle is not blocked. (2) Check the dilution of the sperm nuclei and/or the injection volume delivered during transplantation to be sure that they are appropriate.
     
    Problem: Many embryos die during gastrulation.
     
    [Step 27]
     
    Solution: Try not to damage sperm nuclei during their preparation or during the enzyme reaction. Decondensed nuclei are very fragile and must be transplanted into eggs very soon. Do not place decondensed nuclei on ice.
     
    Problem: The number of embryos expressing the transgene of interest is low.
     
    [Step 28]
     
    Solutions: (1) Make sure that the enzymes used for either linearization or the transgenic reaction do not digest within your construct. (2) Increase the amount of enzyme used for the reaction by diluting it less.
     
    DISCUSSION
     
    One person can transplant sperm nuclei into several hundred to thousands of eggs in a typical experiment. About 30%-40% of these transplanted eggs typically develop into normally cleaving four-cell stage embryos. About 60%-80% of these embryos proceed through gastrulation normally, while the other 20%-40% exhibit gastrulation abnormalities resulting from chromosomal damage to the sperm nuclei or physical damage to the egg occurring during transplantation. Thus, ~20%-30% of the eggs initially injected with nuclei proceed to post-gastrula stages, and ~10%-50% of these embryos show stable expression of transgenes. Since Xenopus embryos can be obtained rapidly, at low cost, and in large numbers, this technique provides a powerful approach for generating transgenic embryos in large numbers.
     
    Transgenesis can be used in many applications: (1) to misexpress genes during development, (2) to label specific structures, using, for example, fluorescent proteins, and (3) to study the regulation of genes. Using this method, the transgene integrates into the genome as a concatemer (5-35 copies; Kroll and Amaya 1996). Therefore, two different constructs mixed in the same reaction cointegrate into the same site of the genome at high frequency (80%-90%; Hartley et al. 2001). To distinguish transgenic embryos, a marker gene (e.g., the {gamma}-crystallin promoter driving GFP) can be co-integrated with a desired transgene. In cases where the effects of misexpression are subtle, it may be difficult to rely solely on F0 transgenic embryos for the analysis. The reason for this is that each F0 animal is unique; i.e., each carries a different copy number of transgenes and distinct sites of integration. However, by establishing transgenic lines, this variability can be overcome (Hartley et al. 2002).
     
    REFERENCES
     
    Hartley, K.O., Hardcastle, Z., Friday, R.V., Amaya, E., and Papalopulu, N. 2001. Transgenic Xenopus embryos reveal that anterior neural development requires continued suppression of BMP signaling after gastrulation. Dev. Biol 238: 168-184.
     
    Hartley, K.O., Nutt, S.L., and Amaya, E. 2002. Targeted gene expression in transgenic Xenopus using the binary Gal4-UAS system. Proc. Natl. Acad. Sci. 99: 377-382.
     
    Kroll, K.L. and Amaya, E. 1996. Transgenic Xenopus embryos from sperm nuclear transplantations reveal FGF signaling requirements during gastrulation. Development 122: 3173-3183.
     
    Copyright © 2007 by Cold Spring Harbor Laboratory Press. Online ISSN: 1559-6095 Terms of Service All rights reserved. Anyone using the procedures outlined in these protocols does so at their own risk. Cold Spring Harbor Laboratory makes no representations or warranties with respect to the material set forth in these protocols and has no liability in connection with their use. Materials used in these protocols may be considered hazardous and should be used with caution. For a full listing of cautions regarding these material, please consult:
    CSH Protocols; 2007; doi:10.1101/pdb.prot4838
    http://www.cshprotocols.org/cgi/content/full/2007/18/pdb.prot4838
    CSH Protocols; 2007; doi:10.1101/pdb.prot4839
    http://www.cshprotocols.org/cgi/content/full/2007/18/pdb.prot4839
    CSH Protocols; 2007; doi:10.1101/pdb.prot4840
    http://www.cshprotocols.org/cgi/content/full/2007/18/pdb.prot4840

     
    All rights reserved. No part of these pages, either text or images, may be used for any reason other than personal use. Reproduction, modification, storage in a retrieval system or retransmission, in any form or by any means-electronic, mechanical, or otherwise-for reasons other than personal use is strictly prohibited without prior written permission.